Heron Therapeutics
HRTX
#8263
Rank
NZ$0.27 B
Marketcap
$1.81
Share price
-5.36%
Change (1 day)
-16.15%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.00. In 2022 the company made an earnings per share (EPS) of -$2.96 an increase over its 2021 EPS that were of -$3.85.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-34.59%
2022-$2.96-23.11%
2021-$3.85-10%
2020-$4.28-0%
2019-$4.281.21%
2018-$4.23-32.7%
2017-$6.28-19.34%
2016-$7.7954.76%
2015-$5.031.73%
2014-$4.95-16.23%
2013-$5.9191.67%
2012-$3.08-31.45%
2011-$4.49-27.06%
2010-$6.16-43.75%
2009-$10.95-57.33%
2008-$25.68-82.92%
2007-$150.2920.61%
2006-$124.61175.76%
2005-$45.19-21.43%
2004-$57.51100%
2003-$28.76-38.24%
2002-$46.56161.54%
2001-$17.80-106.46%
2000$275.402051.55%
1999$12.80839.73%
1998$1.36-105.48%
1997-$24.87-88.16%
1996-$210.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.23-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.24-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.79 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.69-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.82 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA